Kenaheal Injection contains Triamcinolone Acetonide 40mg, a potent synthetic corticosteroid with anti-inflammatory, immunosuppressive, and antipruritic properties. It is indicated for the management of various inflammatory and allergic conditions, including severe allergic reactions, dermatologic disorders, rheumatic diseases, and certain respiratory ailments. The corticosteroid acts by inhibiting the release of inflammatory mediators and suppressing immune responses, thereby reducing swelling, redness, and pain. Kenaheal Injection is administered intramuscularly or intra-articularly, depending on the clinical condition and physician’s discretion. Dosage and duration of therapy should be individualized according to the severity of the disease and patient response, with careful monitoring to minimize potential adverse effects. Common side effects may include local irritation, transient hyperglycemia, and fluid retention, while prolonged use can lead to adrenal suppression, osteoporosis, and increased susceptibility to infections. Contraindications include systemic fungal infections and known hypersensitivity to corticosteroids. Caution is advised in patients with diabetes, hypertension, peptic ulcer disease, or psychiatric disorders. Kenaheal Injection should be used under strict medical supervision, ensuring appropriate evaluation of risks versus benefits to optimize therapeutic outcomes.